Duration of eptifibatide infusion after percutaneous coronary intervention and outcomes among high-risk patients with non-ST-segment elevation acute coronary syndrome: insights from EARLY ACS

BACKGROUND AND OBJECTIVES: Eptifibatide is indicated during percutaneous coronary intervention (PCI) with continuation for 18–24 hours post procedure but is associated with bleeding. We examined the efficacy and safety of shorter post-PCI eptifibatide infusions in high-risk non-ST-segment elevation...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Hess, Connie N, Schulte, Phillip J, Newby, L Kristin, Steg, Philippe Gabriel, Dalby, Anthony J, Schweiger, Marc J, Lewis, Basil S, Armstrong, Paul W, Califf, Robert M, van de Werf, Frans, Harrington, Robert A
Format: Artigo
Langue:Inglês
Publié: SAGE Publications 2013
Sujets:
Acute Coronary Syndromes
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3821813/
https://ncbi.nlm.nih.gov/pubmed/24222836
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2048872612474922
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires